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Abstract
Multimodality imaging based on multifunctional nanocomposites holds great promise to fundamentally augment
the capability of biomedical imaging. Specifically, photoacoustic and fluorescence dual-modality imaging is gaining
much interest because of their non-invasiveness and the complementary nature of the two modalities in terms of
imaging resolution, depth, sensitivity, and speed. Herein, using a green and facile method, we synthesize indocyanine
green (ICG) loaded, polyethylene glycol (PEG)ylated, reduced nano-graphene oxide nanocomposite (rNGO-PEG/ICG) as
a new type of fluorescence and photoacoustic dual-modality imaging contrast. The nanocomposite is shown to have
minimal toxicity and excellent photoacoustic/fluorescence signals both in vitro and in vivo. Compared with free ICG,
the nanocomposite is demonstrated to possess greater stability, longer blood circulation time, and superior
passive tumor targeting capability. In vivo study shows that the circulation time of rNGO-PEG/ICG in the
mouse body can sustain up to 6 h upon intravenous injection; while after 1 day, no obvious accumulation of
rNGO-PEG/ICG is found in any major organs except the tumor regions. The demonstrated high fluorescence/
photoacoustic dual contrasts, together with its low toxicity and excellent circulation life time, suggest that the
synthesized rNGO-PEG/ICG can be a promising candidate for further translational studies on both the early
diagnosis and image-guided therapy/surgery of cancer.
Keywords: Reduced nano-graphene oxide, Indocyanine green, Photoacoustic/fluorescence dual-modality
imaging, Molecular imaging
Background
Real-time near infrared (NIR) fluorescence imaging
combined with passively or actively targeted NIR probes
is becoming a promising approach that can be translated
for clinical applications such as the identification of
tumor margins intraoperatively [1–3]. To date, many
groups have successfully demonstrated NIR fluores-
cence imaging with various NIR probes to identify
neoplastic tissues in both preclinical and pilot clinical
studies [4–7]. However, due to the strong optical scat-
tering in biological tissue, the resolution of fluores-
cence imaging decreases dramatically as the imaging
depth increases [8], which limits the effective imaging
depth of this technology. Photoacoustic imaging is a
rapidly growing hybrid imaging modality, which is
based on the detection of acoustic waves upon the
absorption of pulsed laser energy by either endogen-
ous tissue chromophores or exogenous contrast
agents [9, 10]. As the generated photoacoustic (ultra-
sonic) waves are generally two to three orders of
magnitude less scattered in biological tissue compared
with optical waves, photoacoustic imaging not only
possesses the high sensitivity and specificity of optical
imaging but also offers high spatial resolution at great
depths (up to several centimeters) [11, 12]. While the
spatial resolution at large depths of photoacoustic
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imaging is better than that of fluorescence imaging, the
advantages of fluorescence imaging should not be dimin-
ished given its extremely high sensitivity and imaging
speed for a large field-of-view. Hence, these two imaging
modalities are complementary to each other in terms of
imaging resolution, depth, sensitivity, and speed. As a re-
sult, for many molecular imaging applications, it is highly
desirable to develop and synthesize photoacoustic/fluores-
cence dual-modality nanoprobes.
Because of its intrinsic absorption and emission maxima
in the NIR region, indocyanine green (ICG) is regarded as
an excellent dual-modality contrast agent for both fluores-
cence and photoacoustic imaging. Its NIR absorption
maxima at 740 nm guarantees an effective penetration of
light for both fluorescence and photoacoustic excitation,
while the 800 nm fluorescence emission maxima permits
a highly sensitive detection of the fluorescent photons
generated in deep tissue. Moreover, ICG has been ap-
proved by the Food and Drug Administration (FDA) for a
number of clinical applications [13, 14], such as ophthal-
mic imaging, and the assessment of cardiac output, hep-
atic functions, and blood flow [15]. However, ICG
molecules are also known to have several major limita-
tions for in vivo imaging, including concentration-
dependent aggregation in aqueous solutions [16], and
rapid clearance from the bloodstream [17]. To overcome
these challenges, researchers have tried to incorporate
ICG into poly(D, L–lactide–co–glycolide) (PLGA) and
liposome to construct a nanoparticle delivery system [18]
or combine ICG with graphene oxide (GO) to form a
nanocomposite via π–π stacking interactions [19]. As a re-
sult, the stability and circulation time, as well as the bio-
compatibility of ICG, can be greatly improved. However,
liposome is known to suffer from relatively poor stability,
and the loading ratio of PLGA and GO delivery systems
are considered to be relatively low [18, 20, 21].
During the past few years, reduced nano-graphene
oxide (rNGO), a derivative of graphene oxide, has been
used by many researchers to deliver aromatic molecules
with high loading efficiency, due to its rich π–π conjuga-
tion structures [21–23]. Aromatic molecules such as
doxorubicin (DOX), ICG, and camptothecin (CPT) can
be effectively adsorbed on the rNGO surfaces by π–π
stacking and hydrophobic interactions [24–26]. It is re-
ported that functionalized rNGO can load more aro-
matic molecules than that of NGO and liposome [20, 21,
27, 28]. Moreover, rNGO has high optical absorption in
the NIR regime. Thus, compared with other ICG deliv-
ery systems such as those based on PLGA or liposome,
the photoacoustic signals at 780 nm (the absorption
peak of ICG) can be greatly enhanced if rNGO is used
as the carrier for ICG.
Conventionally, toxic chemical reducing reagents, such
as sodium borohydride, hydrazine, and their derivatives,
are used to reduce NGO. However, the rNGO produced
by these methods often have agglomeration problems,
and the residual toxic reduction reagents may also limit
their in vivo applications [29–31]. Herein, we synthe-
sized rNGO using a facile and green method as reported
in our previous publication [32] and further loaded ICG
onto the surfaces of rNGO with high efficiency to obtain
a new type of multifunctional nanocomposite for both
fluorescence and photoacoustic biomedical imaging appli-
cations. The ICG loaded rNGO-polyethylene glycol (PEG)
(rNGO-PEG/ICG) nanocomposite showed excellent bio-
compatibility, high stability, long blood circulation time,
and high NIR absorption. The loading efficiency of ICG
(weight ratio of ICG to the rest of the nanocomposite)
was also significantly higher compared with that of PLGA
encapsulating ICG nanoparticles reported previously [18].
Therefore, for in vivo applications, the dose of the nano-
composite can be reduced to lower the potential risk of
long-term toxicity. The synthesized rNGO-PEG/ICG was
demonstrated as a new type of excellent multimodality
contrast agent for both photoacoustic and fluorescence
imaging in living mice. The results in the current study
suggest that the rNGO-PEG/ICG fabricated using our
green and facile method can be a promising candidate for
further clinical translational studies on both the diagnosis
and image-guided therapy/surgery of cancer in vivo.
Methods
Synthesis of rNGO-PEG/ICG
Scheme 1 shows the synthesis strategy of rNGO-PEG/
ICG. The NGO-PEG was synthesized following the
method as reported by us previously [32]. In brief, GO
powder was made using a modified Hummer’s method
with expandable graphite flakes (XF NANO Co., Ltd.
China). NGO solution was prepared by sonicating the
GO powder. NaOH (1.2 g) and Cl–CH2–COOH (1.0 g)
were added to the NGO suspension (~2 mg mL−1) and
sonicated for 30 min to obtain carboxylation NGO
(NGO–COOH). The resulting NGO–COOH suspension
was neutralized and purified by multiple rounds of rinsing
and filtration. Four-arm polyethylene glycol-Amine
(5 kDa MW, Creative PEG Works, USA) and NGO-
COOH suspension were reacted at a pH of 6, and
then, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
(4 mmol L−1) and N-hydroxysuccinimide (10 mmol L−1)
(EDC and NHS, Sigma) were added to the above suspen-
sion. The produced NGO-PEG was purified by centrifu-
ging with 30 kDa ultracentrifuge tubes (Millipore) and
dialyzed against distilled water for overnight to remove
any ions. Then, the solution was centrifuged at 12,000g for
30 min to remove any unstable aggregates. After that,
50 mL of the NGO-PEG solution (1 mg mL−1) was trans-
ferred to a sealed glass bottle and then bathed at 90 °C for
24 h. Finally, the resulting rNGO-PEG solution was
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centrifuged at 6000g for 10 min to remove any unstable
aggregates and stored at 4 °C for further use.
Loading of ICG onto rNGO-PEG was implemented by
first adding sufficient ICG (~20 mg) to rNGO-PEG
aqueous suspension (5 mL, 1 mg mL−1) and then stirring
the mixture at 4 °C overnight. The product was repeat-
edly filtered through a 30 kDa filter (Millipore) and cen-
trifuged at 6000g to remove unbound ICG molecules.
The ultimately produced rNGO-PEG/ICG solution was
stored at 4 °C for further use. As a control, ICG was also
loaded onto unreduced NGO-PEG at the same condition
to produce NGO-PEG/ICG. To estimate the amount of
ICG loaded onto NGO-PEG and rNGO-PEG, we first
measured the absorbance of NGO-PEG/ICG and rNGO-
PEG/ICG solutions at 780 nm and then subtracted the
counterparts of NGO-PEG and rNGO-PEG, respectively.
After that, we compared the obtained absorbance with
the standard curve of free ICG to estimate the concen-
tration of the loaded ICG. The standard curve here
means the correlation between the ICG concentration
and its absorbance at the absorption peak, given that the
ICG concentration is in the linear range.
Characterizations
Dynamic light scattering (DLS) analysis was performed
using a Zetasizer Nano ZS system (Malvern Instru-
ments) to characterize the average hydrodynamic diam-
eter. The morphology of the materials was imaged with
atomic force microscopy (AFM, Agilent Technologies
5500, USA) and transmission electron microscopy
(TEM, FEI Tecnai G2 F20 S-Twin, USA). To analyze the
loading ratio of ICG, UV–vis spectra were acquired by
an UV–vis spectrometer (Lambda 25, PerkinElmer,
USA), with the sample in a 1-cm quartz cuvette. Lumi-
nescence spectrometer (F900 Edinburgh Instruments
Ltd, Livingston, UK) was used to measure fluorescence
emission of the sample. To confirm the success of cova-
lent PEG conjugation to NGO as well as the reduction
of NGO-PEG to rNGO-PEG, Fourier transfer infrared
(FT-IR) spectra were recorded on a Magna-IR 750 FT-IR
spectrometer (Nicolet, USA). X-ray photoelectron spec-
troscopy (XPS) measurement was carried out with an
ESCALAB 250XI high performance electron spectrometer
(Thermo, USA). All photoacoustic measurements were
conducted with our custom-built photoacoustic imaging
system, which will be described in the “Photoacoustic and
fluorescence imaging systems” section.
Cell Culture and Cellular Uptake of rNGO-PEG/ICG
A Hela cell line (Helen Lake) was obtained from Ameri-
can Type Culture Collection and cultured at 37 °C in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco,
Grand Island, NY, USA) supplemented with 10 % fetal
calf serum (FCS, Gibco) and 5 % CO2 in a humidified
incubator.
For the cellular uptake study of rNGO-PEG/ICG, Hela
cells were cultured in the confocal dish for 24 h and
then incubated with free ICG and rNGO-PEG/ICG sus-
pension (with 30 μg mL−1 ICG) for 3 h. After that, the
cells were rinsed with phosphate-buffered saline (PBS)
for three times to remove the redundant nanocompos-
ites and subsequently fixed with 4 % paraformaldehyde
solution for 10 min. Then, the cells were washed with
PBS again and stained by 4′,6-diamidino-2-phenylindole
(DAPI, 10 μg mL−1) for 2–3 min. Finally, the stained
cells were imaged with a confocal laser scanning micro-
scope (CLSM, Leica TCS SP5, Wetzlar, Germany), using
405 and 633 nm laser wavelength, respectively, for DAPI
and ICG excitation. In addition, the cell uptake ratios of
free ICG and rNGO-PEG/ICG were analyzed using the
flow cytometry. In brief, the cells were incubated with
rNGO-PEG/ICG for 3 h and then washed by PBS three
Scheme 1 The synthesis route of rNGO-PEG/ICG from NGO. Step 1: PEGylation of NGO, step 2: reduction of NGO-PEG, step 3: loading ICG
onto rNGO-PEG
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times. After digesting the cells, the ICG fluorescence
signals in cells were detected and analyzed by flow
cytometry.
Animal and Tumor Model
Female BALB/c nude mice (4–6 weeks old) were ob-
tained from the Medical Experimental Animal Center of
Guangdong Province (Guangzhou, China). All animal
experiment procedures were approved by the Animal
Study Committee of the Shenzhen Institutes of Ad-
vanced Technology, Chinese Academy of Sciences. The
Hela tumor models were established by subcutaneously
injecting 5 × 106 cells in PBS (200 μL) into the back of
BALB/c nude mice. When the tumor size reached ap-
proximately 100 mm3, the mice were divided into differ-
ent groups (five mice per group) for subsequent
experiments.
Photoacoustic and Fluorescence Imaging Systems
An acoustic-resolution photoacoustic microscopy (AR-
PAM) system was used for all the photoacoustic mea-
surements in this study. The details of the system are
reported in our earlier publication [18]. In brief, the
AR-PAM system consists of a tunable pulsed optical
parametric oscillator (OPO) laser (Vibrant 355 II HE,
Opotek, Carlsbad, USA), a focused ultrasound trans-
ducer (V315-SU, Olympus IMS, Waltham, USA; cen-
tral frequency: 10 MHz; fractional bandwidth: 6 MHz;
N.A.: 0.4), and a precision motorized 3D scanning
stage (PSA2000-11, Zolix, Beijing, China). During ex-
periments, the OPO laser was operated at 780 nm
(peak absorption wavelength of ICG), with a repeti-
tion rate of 10 Hz and a pulse width of 5 ns. The
laser fluence is 2 mJ cm−2 for phantom study and
6 mJ cm−2 for in vivo imaging experiments.
For fluorescence imaging, a commercial three dimen-
sional imaging system (CRi MaestroTM, USA) was used
to acquire the images of both phantom and animal
studies.
In Vitro Toxicity Study
For cytotoxicity assay, approximately 5 × 104 Hela cells/
well were plated in a 96-well plate with medium
(100 μL) in each well and cultured for 24 h. After that,
various concentrations of rNGO-PEG/ICG were added
to the wells. The relative cell viability was assessed by
Cell Counting Kit-8 (CCK-8, Dojindo, Japan) assay after
incubating for 24 and 48 h, respectively.
Fig. 1 Reduction of NGO-PEG. a The average hydrodynamic diameter of NGO, NGO-PEG, and rNGO-PEG. b FT-IR spectra of NGO, NGO-PEG, and
rNGO-PEG. c, d XPS spectra of NGO-PEG and rNGO-PEG. Inset: Photographs of NGO-PEG and rNGO-PEG solutions
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Histology Analysis
rNGO-PEG/ICG (200 μL, ~15 mg kg−1 concentration)
was intravenously injected into five healthy female
BALB/c nude mice. Another five healthy BALB/c nude
mice were used as the untreated control, in which the
same amount of saline was injected intravenously. Then,
all the mice were sacrificed; the major organs of these
mice were harvested, fixed in 10 % neutral buffered for-
malin, processed into paraffin, sectioned at a thickness
of 5–10 μm, stained with hematoxylin & eosin (H&E),
and examined under a digital optical microscope (Cx41,
Olympus).
Results and Discussion
Synthesis and Characterization of rNGO-PEG
As shown in Fig. 1a, the average hydrodynamic diame-
ters of NGO, NGO-PEG, and rNGO-PEG are about 55,
72, and 63 nm, respectively, measured with dynamic
light scattering. FT-IR spectra confirmed the success of
covalent PEG conjugation to NGO as well as the reduc-
tion of NGO-PEG to rNGO-PEG (Fig. 1b). The add-
itional peaks at ~1650 cm−1 in both the NGO-PEG and
rNGO-PEG spectra compared with that of NGO indi-
cated the existence of −NH2 groups, suggesting that the
PEG functional groups were conjugated to NGO suc-
cessfully and the reduction process did not cause a sig-
nificant loss of PEG from rNGO-PEG. As a result, the
biocompatibility of both NGO-PEG and rNGO-PEG was
significantly improved compared with that of NGO. The
increase at the peak of ~1625 cm−1 (C=C) of rNGO-
PEG compared with that of NGO-PEG indicated the res-
toration of π−π structure [33], and the decrease at the
peak of ~1720 cm−1 indicated the removal of C=O (i.e.,
oxygen groups) [34]. Both changes confirmed that the
NGO-PEG was successfully reduced [33, 34].
XPS spectra measurements were also carried out to
provide further proof of the reduction process from
NGO-PEG to rNGO-PEG. The diminished C–O signal
(286.8 eV) and increased C=O (288.0 eV) and C–C sig-
nals (284.6 eV) (Fig. 1c, d) demonstrated the successful
reduction of NGO [35, 36], likely due to the strong re-
ducibility of the four-armed PEG-NH4 originated from
its −NH2 groups [37, 38]. The insets of Fig. 1c, d showed
the color change of NGO-PEG solution from brown to
dark black, which was an additional intuitive evidence
for the reduction of NGO [39].
Characterization of rNGO-PEG/ICG
The morphology of the fabricated rNGO-PEG/ICG was
imaged by AFM. As shown in Fig. 2b and Additional file 1:
Figure S1A, rNGO-PEG/ICG exhibited a lamellar structure
with a thickness of about 2.2 nm, which was larger than
that of rNGO-PEG (about 1.6 nm, Fig. 2a), likely owing to
the ICG physical adsorption onto rNGO-PEG. In addition,
after exposing under the 780 nm laser (6 mJ cm−2) for
30 min (Additional file 1: Figure S1), the morphology of
Fig. 2 Synthesis and characterization of rNGO-PEG/ICG. a, b AFM images of rNGO-PEG and rNGO-PEG/ICG. c UV–vis absorption spectra of free
ICG, rNGO-PEG, and rNGO-PEG/ICG solutions. d Fluorescence spectra of ICG and rNGO-PEG/ICG solutions with the same concentration of ICG
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rNGO-PEG/ICG had no significant change, demonstrating
the great photostability of rNGO-PEG/ICG. UV–vis spec-
tra showed that the absorbance of rNGO-PEG had in-
creased by ~threefold over that of NGO-PEG in the NIR
range (700–900 nm) (Fig. 2c and Additional file 1: Figure
S2A). In addition, the feature peak (at ~780 nm) of ICG
absorption can be seen in the spectra of rNGO-PEG/ICG
(Fig. 2c), indicating that ICG was successfully loaded onto
rNGO-PEG via π–π stacking and hydrophobic interac-
tions. The loading capacity of rNGO-PEG (about 180 % w/
w) was about twofold than that of NGO/PEG (about 86 %
w/w) (Additional file 1: Figure S2B), which was probably
because of the repaired aromatic ring structures that in-
creased the π–π stacking and hydrophobic interactions
between rNGO-PEG and the aromatic ICG molecules.
Figure 2d shows that the fluorescence spectrum of rNGO-
PEG/ICG agrees well with that of free ICG of the same
ICG concentration, and the fluorescence intensity decrease
of rNGO-PEG/ICG compared with that of free ICG is
presumably due to the photo quenching of ICG upon
conjugation to rNGO. This result indicates that the
loading process did not cause significant perturbation
to the fluorescence property of ICG. To evaluate the
stability of rNGO-PEG/ICG, we monitored the disper-
sions of rNGO-PEG/ICG in water, cell medium
(DMEM), fetal bovine serum (FBS), and PBS
solutions. The results showed that no obvious aggre-
gation was found in the solutions and rNGO-PEG/ICG
remained stable for about 1 month at 4 °C (Additional
file 1: Figure S3).
In Vitro Cellular Uptake
To confirm the uptake of rNGO-PEG/ICG by tumor
cells, Hela cells incubated with free ICG and rNGO-
PEG/ICG were observed under a commercial confocal
laser scanning microscope. As shown in Fig. 3, com-
pared with the blank control and free ICG treated
groups, the rNGO-PEG/ICG treated group has shown a
significant fluorescence of ICC surrounding the DAPI
stained Hela nuclei. Additional file 1: Figure S4 shows
that the cells cultured with free ICG and rNGO-PEG/
ICG, respectively, had 9.1 and 63.5 % of uptake ratio.
The high efficient cell uptake of rNGO-PEG/ICG may
be beneficial for cancer therapy.
Photoacoustic Imaging of Phantoms
Figure 4 shows the AR-PAM results of various phantoms
with the excitation wavelength tuned at 780 nm. Figure 4a
shows the maximum amplitude projection (MAP) photo-
acoustic images of NGO-PEG, rNGO-PEG, NGO-PEG/
ICG, and rNGO-PEG/ICG phantoms with the same NGO
concentration and whole blood as a control. It can be seen
Fig. 3 Confocal fluorescence microscopic images of Hela cells treated with PBS (as blank control), free ICG, and rNGO-PEG/ICG for 3 h. The cell
nuclei were stained by DAPI
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that (1) the photoacoustic signal intensity of rNGO-PEG
was stronger than that of NGO-PEG because of the op-
tical absorption enhancement in the NIR range after
reduction; (2) compared with that of NGO-PEG and
rNGO-PEG, the photoacoustic signal intensity of both
NGO-PEG/ICG and rNGO-PEG/ICG were significantly
enhanced by the distinct absorption of ICG at 780 nm;
and (3) compared with NGO-PEG/ICG and blood, the
photoacoustic signal of rNGO-PEG/ICG was much stron-
ger, primarily because of the higher ICG loading efficiency
onto rNGO-PEG (also because of the enhanced absorp-
tion upon reduction from NGO-PEG to rNGO-PEG).
Figure 4b shows that the photoacoustic signal is in-
creasing linearly (R2 = 0.99) with the rNGO-PEG/ICG
concentration, within the range (≤1 mg mL−1) used in
our measurements. In addition, the MAP photoacous-
tic images of the phantoms are also shown in the
inset of Fig. 4b.
Fluorescence and Photoacoustic Imaging of Phantoms
Figure 4c shows both the photoacoustic and fluores-
cence images of a rNGO-PEG/ICG phantom covered
with a 5-mm-thick agarose gel containing 0.5 % intrali-
pid to mimic the optical scattering of biological tissue. It
can be seen that the photoacoustic image presents a
much sharper boundary of the target in this case. Fur-
ther, fluorescence and photoacoustic MAP images of a
polyethylene (PE) tube filled with rNGO-PEG/ICG were
acquired under two circumstances: (1) in non-scattering
medium (water) and (2) when the tube was implanted
subcutaneously into a mouse leg. As shown in Fig. 4d,
when there is no strong optical scattering, both the
fluorescence and photoacoustic MAP images agree well
with the photograph of the tube (i.e., the real shape of
the tube). However, when the PE tube was subcutane-
ously implanted into the leg of a living mouse and thus
covered by its skin, muscle, and connective tissue, the
Fig. 4 Photoacoustic (PA) imaging of various phantom samples, as well as comparisons between photoacoustic and fluorescence (FL) imaging.
a Photoacoustic images of NGO-PEG, rNGO-PEG, NGO-PEG/ICG, and rNGO-PEG/ICG with the same GO concentration and whole blood. b The
linear relationship between PA signal intensity and the concentration of rNGO-PEG/ICG. Inset: Photoacoustic images of various concentrations of
rNGO-PEG/ICG. c Photoacoustic and FL images of rNGO-PEG/ICG covered with 5-mm-thick agarose gel containing 0.5 % intralipid. d White light
(WL), FL, and PA MAP images of a PE tube filled with rNGO-PEG/ICG. e White light, FL, and PA MAP images of a mouse with the rNGO-PEG/ICG
filled PE tube implanted subcutaneously at the dorsal aspect of the leg. The white dash box indicates the location of the tube
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fluorescence image was seriously blurred due to the
strong optical scattering. On the contrast, the photo-
acoustic image was still able to clearly delineate the
shape of the tube (Fig. 4e), demonstrating the unique
advantage of photoacoustic technology for high reso-
lution imaging at a relatively large depth in scattering
biological tissue.
In Vivo Fluorescence and Photoacoustic Imaging
Fluorescence imaging was carried out to investigate the
biodistribution of rNGO-PEG/ICG in tumor-bearing mice.
Figure 5 depicts a typical fluorescence signal distribution
within the mouse body as a function of time after tail vein
injection of rNGO-PEG/ICG (150 μL, ~15 mg kg−1) and
free ICG (as the control group, 10 mg kg−1). For both
rNGO-PEG/ICG and free ICG, it was found that (Fig. 5a)
the signals started to gradually accumulate towards internal
organs such as the liver and intestine from 0.5 to 6 h (dur-
ing this period, a significant accumulation in the tumor re-
gion was also found in the rNGO-PEG/ICG group). More
importantly, along with time, for the rNGO-PEG/ICG
group, the accumulation of the material towards the tumor
region was becoming more and more significant—after
48 h; well detectable fluorescence signals were found only
in the tumor region. For the free ICG control group, as
expected, the clearance process was rather rapid, and the
majority of the dye was cleared out of the body after ~6 h,
with no significant accumulation observed in the tumor re-
gion. These results suggest that, compared with free ICG,
rNGO-PEG/ICG has greatly enhanced the permeability
and retention (EPR) effect to enable effective imaging of
tumor in vivo. To further validate these results, we excised
the tumors and harvested the major organs of the mice at
48 h post injection of the samples. Figure 5b shows the
fluorescence signals of the excised major organs (heart,
liver, spleen, lung, and kidney) and tumors from the
tumor-bearing mice 48 h after tail vein injection of the
rNGO-PEG/ICG and free ICG; Fig. 5c further shows the
fluorescence signals of the tumor slices. From both
Fig. 5b, c, it can be seen that significant fluorescence
signals can only be observed in the tumors of the
rNGO-PEG/ICG-injected mice, but not the free ICG-
injected mice.
Figure 6a, b, respectively, shows the cross-sectional
and three-dimensional ultrasonic, photoacoustic, and
fused images of the tumor region as a function of
time, upon the tail vein injection of rNGO-PEG/ICG
(150 μL, ~15 mg kg−1). In addition to the position
and rough contour of the tumor that can be identi-
fied with ultrasound imaging, photoacoustic images
further show the depth-resolved rNGO-PEG/ICG distri-
bution in the tumor region at high resolution. Such infor-
mation can be vital for both image-guided tumor therapy
and for assessing certain functional characteristics (e.g.,
Fig. 5 In vivo fluorescence imaging. a Fluorescence signal distribution within the tumor-bearing mouse body as a function of time after tail vein
injection of ICG and rNGO-PEG/ICG. White dash line encircles the tumor region. b, c The ex vivo fluorescence signal of the excised major organs
(tumor, heart, liver, spleen, lung, and kidney) and tumor slices of mice at 48 h post injection
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vascularization) of cancer. As can be seen, the dynamics
of the photoacoustic signal in the tumor region exhibits
similar features to that of fluorescence imaging (Fig. 5a).
It was reported that, in order to take full advantage of
the EPR effect, the hydrodynamic diameter (HD) of the
nanoparticles should be in the range of 10 to 200 nm,
and the nanoparticles should be of a hydrophilic (polar
or zwitterionic) surface coating for an extended blood
circulation time and undesirable clearance by the im-
mune system [40–42]. In our experiments, excellent
passive tumor-targeting capability of rNGO-PEG/ICG
nanocomposite has been demonstrated through both
fluorescence and photoacoustic imaging, which may be
attributed to the following two reasons: (1) the 80-nm
diameter is within the optimal hydrodynamic size range
for efficient delivery and accumulation of the nanocom-
posite in the tumor region and (2) the PEG layer on the
surface of rNGO-PEG/ICG can effectively reduce its
clearance by the reticuloendothelial system, resulting in
a prolonged blood circulation time.
In Vitro and In Vivo Toxicity Assessment
The toxicity of rNGO-PEG/ICG was assessed through
both in vitro and in vivo experiments. As shown in
Fig. 7a, no significant decrease of cell viability is ob-
served at 24 and 48 h after the treatment of rNGO-
PEG/ICG with a concentration varying from 0 to
100 μg mL−1. Figure 7b shows the H&E staining of the
major organs (heart, liver, spleen, kidney, and lung) col-
lected from a representative mouse on day 7 after the in-
jection of rNGO-PEG/ICG and free ICG. Compared
with the free ICG and blank control groups, no obvious
tissue damages are shown in the rNGO-PEG/ICG group.
Conclusions
Utilizing a green reduction strategy, we fabricated
rNGO-PEG with excellent biocompatibility. Further,
rNGO-PEG/ICG nanocomposite was synthesized by effi-
ciently loading ICG onto the rNGO-PEG surfaces via
π–π stacking. The developed nanocomposite was shown
to possess high stability, strong fluorescence, and greatly
enhanced NIR absorption over either ICG or rNGO-
PEG alone. As a result, it can be an excellent agent for
photoacoustic/fluorescence dual-modality imaging. In
vitro studies showed that the nanocomposite could be
efficiently uptaken by tumor cells without causing a sig-
nificant decrease of cell viability. Moreover, upon tail
vein injection of rNGO-PEG/ICG into tumor-bearing
Fig. 6 In vivo photoacoustic imaging. a B-scan and b 3D ultrasound (US) and PA images of the tumor region obtained at 1, 3, 6, 24, and 48 h
post tail vein injection of rNGO-PEG/ICG. The US images delineated the skin and tumor boundaries, while the PA images showed the accumula-
tion and distribution of the nanocomposite within the tumor region
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mice, significant contrast enhancement was seen in the
tumor regions in both photoacoustic and fluorescence
images acquired in vivo, throughout the entire imaging
period. Overall, our results show that the developed
rNGO-PEG/ICG nanocomposite is capable of effectively
targeting tumor in vivo via the EPR effect. Meanwhile, it
provides high contrasts for both fluorescence and photo-
acoustic imaging. The excellent passive targeting and
imaging properties, together with its low toxic demon-
strated in vitro and in vivo, suggest that the rNGO-PEG/
ICG nanocomposite synthesized in this work can be of
great potential for further clinical translation for both
the diagnosis and image-guided therapy of cancer.
Additional file
Additional file 1: The supplementary characterization results of
rNGO-PEG/ICG. (DOCX 2405 kb)
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